NAPS Global India IPO has received a muted response from investors so far, with the subscription reaching nearly 42 per cent ...

The NAPS Global India IPO launched on March 5, priced at ₹90 per share, with a minimum bid of 1,600 shares. The company, a ...

Over $100 Million Invested in the U.S. FREMONT, CA - March 5, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on inno ...

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs 05.03.2025 / 22:07 CET/CEST The issuer is solely responsible for the content of this ...

Apeloa Pharmaceutical ( www.apeloa.com ), part of Hengdian Group, is a top-five pharmaceutical CDMO in China with the largest manufacturing capacity of the five. It was founded in 1989 and has been ...

Symbiosis Pharmaceutical Services has completed the latest inspection by the U.S. FDA of its facilities in Scotland.

NAPS Global India's SME IPO opened for bidding, aiming to raise Rs 12 crore with a price band of Rs 90 per share.

The CMO/CDMO market is set to evolve rapidly, driven by innovation, outsourcing trends, and the biopharmaceutical revolution.

The Kia EV4 is poised to make a significant impact on the electric vehicle (EV) market by offering a unique and innovative ...